Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M
Sang S
Orindi B
Njau I
Karanja H
Kamau N
Gitonga JN
Mugo D
Wright D
Nyagwange J
Kutima B
Omuoyo D
Mwatasa M
Ngetsa C
Agoti C
Cheruiyot S
Nyaguara A
Munene M
Mturi N
Oloo E
Ochola-Oyier L
Mumba N
Mauncho C
Namayi R
Davies A
Tsofa B
Nduati EW
Aliyan N
Kasera K
Etyang A
Boyd A
Hill A
Gilbert S
Douglas A
Pollard A
Bejon P
Lambe T
Warimwe G
COVVaccine Trial Group
Wellcome Open Res, (2023). 8:182
A rapid review of community engagement and informed consent processes for adaptive platform trials and alternative design trials for public health emergencies.Davies A
Ormel I
Bernier A
Harriss E
Mumba N
Gobat N
Schwartz L
Cheah PY
Wellcome Open Res, (2023). 8:194
A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses.Ngwenya N
Ilo Van Nuil J
Nyirenda D
Chambers M
Cheah PY
Seeley J
Chi P
Mafuleka L
Nkosi B
Kamuya D
Davies A
Schneiders ML
Mumba N
Dlamini S
Desmond N
Marsh V
Rippon D
Parker M
Molyneux S
Wellcome Open Res, (2023). 7:48
Always leave the audience wanting more: An entertaining approach to stimulate engagement with health research among publics in coastal Kenya through 'Magnet Theatre'.Sanga G
Jao I
Mumba N
Mwalukore S
Kamuya D
Davies A
Wellcome Open Res, (2021). 6:2
Evolution of a programme to engage school students with health research and science in Kenya.Davies A
Mwangome N
Yeri B
Mwango G
Mumba N
Marsh V
Kamuya D
Molyneux S
Kinyanjui S
Jones C
Wellcome Open Res, (2019). 4:39
